Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
StateLouisianaEnacted
SB 387: HEALTH/ACC INSURANCE: Provides relative to pharmacy benefit managers. (1/1/27) (EN INCREASE SG EX See Note)
Adam Bass
SB 387 status: Enacted — Signed by the Governor. Becomes Act No. 914 (updated Jun 12, 2026).
Source
OpenStates
Confidence
Low
Analysis basis
OpenStates summary
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
56OUT OF 100
Score:56/100 civic fit
Risk:Moderate Risk
Impact:Moderate Impact 60/100
Constitutionality85%
Bipartisan50%
Public opinion70%
Bill summary
This bill creates new rules for **Pharmacy Benefit Managers** (the companies that act as middlemen between insurance plans and drug companies). If passed: * **What it does:** It changes how these companies operate. * **When it starts:** January 1, 2027. * **Cost:** It will require more state funding to implement. * **Status:** It is currently being debated in the State Senate.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Mixed / Neutral
55%
Benefits
- Increased regulatory oversight of financial intermediaries
- Potential for reduced drug cost variability
- Standardized operational requirements for industry participants
Risks
- Additional state funding required for implementation
- Compliance costs for pharmacy benefit managers
- Potential for operational cost pass-through to insurance plans
Society
Mixed / Neutral
55%
Benefits
- Potential for improved patient access to essential medications
- Enhanced consumer protection against intermediary pricing practices
- Greater consistency in health plan coverage rules
Risks
- Risk of insurance premium adjustments following new mandates
- Uncertain impact on specific medication formularies
- Complexity in implementation may limit initial consumer benefits
Technology Industry
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Civic Accountability
Positive outlook
60%
Benefits
- Establishes statutory oversight for non-transparent intermediaries
- Implements formal state-led regulatory authority over PBMs
- Requires accountability for financial transactions in drug procurement
Risks
- Administrative complexity in verifying PBM compliance
- Requires ongoing state fiscal monitoring
- Potential for regulatory capture over time
Public Health & Safety
Mixed / Neutral
55%
Benefits
- Improved oversight of medication access channels
- Reduced barriers to affordable prescription drug acquisition
- Strengthened regulation of intermediaries impacting health outcomes
Risks
- Risk of coverage disruptions during compliance transition
- Reliance on intermediary compliance to prevent medication shortages
- Potential for unintended impacts on health plan affordability
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
OpenStates
Official bill text or data from OpenStates.
Confidence
Low
Information is limited or incomplete.
Analysis basis
OpenStates summary
Source used for this bill's analysis.
Source note
LegiScan returned a PDF-only document. PDF extraction is not enabled in this build, so the pipeline used a safer fallback.
Analysis scope
Source provided is an abstract; full text of regulatory requirements is unavailable.
04
Where it stands
Official recordSigned by the Governor. Becomes Act No. 914.
- IntroducedComplete
- CommitteeComplete
- Chamber votesComplete
- Final agreementComplete
- GovernorComplete
- EnactedComplete
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.